Voltarol Pain Relief Gel, 12 Hour Joint Pain Relief 2.32% Gel (packaging may vary), 50 g (Pack of 1)

Product Information

Selective serotonin reuptake inhibitors (SSRIs): Concomitant administration of SSRI's may increase the risk of gastrointestinal bleeding (see section 4.4 Special warnings and precautions for use). Bursitis is a condition that affects the small, synovial fluid-filled sacs – called bursae – that cushion the bones and tendons near your joints. Bursitis most often occurs in joints that are used in frequent, repetitive motions. The most common locations of burstitis are the shoulder, elbow, and hip. However, it can also occur in the knee, heel, or at the base of your big toe. Gout Diclofenac is rapidly and completely absorbed from sugar-coated tablets. Food intake does not affect absorption. The suppositories should be inserted well into the rectum. It is recommended to insert the suppositories after passing stools.

The low systemic absorption of Voltarol Emulgel renders overdose very unlikely. However, undesirable effects, similar to those observed following an overdose of diclofenac tablets, can be expected if Voltarol Emulgel is inadvertently ingested (e.g. 1 tube of 100g contains the equivalent of 1000mg of diclofenac sodium). Patients with a history of GI toxicity, particularly when elderly, should report any unusual abdominal symptoms (especially GI bleeding). Children (aged 1-12 years) with juvenile chronic arthritis: 1-3mg/kg per day divided into 2 or 3 doses (12.5mg and 25mg suppositories only). To remove the seal before first use, use the reverse side of the cap to insert, twist and remove the seal from the tube.Gastritis, gastrointestinal haemorrhage, haematemesis, diarrhoea haemorrhagic, melaena, gastrointestinal ulcer with or without bleeding or perforation (sometimes fatal particularly in the elderly). To remove the seal before first use, unscrew and remove the cap. Use the reverse side of the cap to insert, twist and remove the seal from the tube.

Clinical trial and epidemiological data consistently point towards increased risk of arterial thrombotic events (for example myocardial infarction or stroke) associated with the use of diclofenac, particularly at high dose (150mg daily) and in long term treatment . Repeated oral administration of Voltarol Rapid for 8 days in daily doses of 50 mg t i d does not lead to accumulation of diclofenac in the plasma. If your medicine becomes discoloured or shows any sign of deterioration, return it to your pharmacist. If you get any side effects which worry you (even side effects not listed in this leaflet), talk to your doctor or pharmacist. The systemic concentration of diclofenac is lower after topical administration, compared to oral formulations. With reference to experience from treatment with NSAIDs with systemic uptake, the following is recommended:

Due to an increased possibility of side effects, take care if you are using any other medicine containing diclofenac or painkillers known as NSAIDs, such as aspirin or ibuprofen.

Although there have been no reported adverse events, there is a theoretical possibility that patients receiving other medications which may prolong bleeding time, or with known haemostatic defects may experience exacerbation with Voltarol Ophtha. Squeeze out an amount ranging in size from a one penny to two pence coin, depending on the size of the affected area.Like other drugs that inhibit prostaglandin synthetase activity, diclofenac and other NSAIDs can precipitate bronchospasm if administered to patients suffering from or with a previous history of, bronchial asthma. Patients with congestive heart failure (NYHA-I) or significant risk factors for cardiovascular disease should be treated with diclofenac only after careful consideration. Since cardiovascular risks with diclofenac may increase with dose and duration of exposure, the lowest effective daily dose should be used and for the shortest duration possible (see section 4.4 Special warnings and precautions for use). Voltarol must not be used during the last 3 months of pregnancy, as it could harm your unborn child or cause problems at delivery. This medicine should only be used under medical advice during the first 6 months of pregnancy and the dose should be kept as low and duration of treatment as short as possible. Skin rash with blisters; hives. (These side effects are likely to affect 1 to 10 people in every 10,000). Treatment of acute post-operative pain should be limited to 4 days treatment (12.5mg and 25mg suppositories only).